Axon Enterprise, Inc $AXON Shares Purchased by PFG Investments LLC

PFG Investments LLC increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 4.1% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,760 shares of the biotechnology company’s stock after buying an additional 147 shares during the period. PFG Investments LLC’s holdings in Axon Enterprise were worth $3,113,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. TABR Capital Management LLC acquired a new stake in Axon Enterprise in the 2nd quarter valued at about $271,000. Institute for Wealth Management LLC. grew its position in shares of Axon Enterprise by 0.3% in the second quarter. Institute for Wealth Management LLC. now owns 20,694 shares of the biotechnology company’s stock valued at $17,133,000 after purchasing an additional 68 shares during the last quarter. Truist Financial Corp grew its position in shares of Axon Enterprise by 14.9% in the second quarter. Truist Financial Corp now owns 10,644 shares of the biotechnology company’s stock valued at $8,813,000 after purchasing an additional 1,378 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new stake in shares of Axon Enterprise in the second quarter valued at approximately $594,000. Finally, Lee Johnson Capital Management LLC grew its position in shares of Axon Enterprise by 19.1% in the second quarter. Lee Johnson Capital Management LLC now owns 8,687 shares of the biotechnology company’s stock valued at $7,192,000 after purchasing an additional 1,393 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. UBS Group reiterated a “neutral” rating and set a $840.00 target price (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Needham & Company LLC reaffirmed a “buy” rating and set a $870.00 price objective on shares of Axon Enterprise in a research note on Wednesday, September 24th. JPMorgan Chase & Co. raised their price target on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research note on Thursday, July 17th. Bank of America raised their price target on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Finally, Piper Sandler started coverage on shares of Axon Enterprise in a research note on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 price target on the stock. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $841.64.

Insider Transactions at Axon Enterprise

In related news, CFO Brittany Bagley sold 5,000 shares of Axon Enterprise stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the transaction, the chief financial officer owned 93,592 shares in the company, valued at approximately $66,813,456.96. This trade represents a 5.07% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the completion of the transaction, the president directly owned 238,379 shares in the company, valued at $177,892,712.54. This represents a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 49,932 shares of company stock valued at $37,978,216 in the last ninety days. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Price Performance

AXON opened at $717.64 on Wednesday. The company’s 50 day simple moving average is $757.83 and its 200 day simple moving average is $704.96. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a 1 year low of $395.37 and a 1 year high of $885.91. The stock has a market capitalization of $56.34 billion, a PE ratio of 177.20, a P/E/G ratio of 27.80 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. The company had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. Axon Enterprise’s revenue for the quarter was up 32.6% on a year-over-year basis. During the same quarter last year, the business earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, sell-side analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.